253 related articles for article (PubMed ID: 12422606)
1. Evaluation of immunofluorescence test (IFT) and immuno (western) blot (WB) test in patients with erythema migrans.
Ruzić-Sabljić E; Maraspin V; Cimperman J; Lotric-Furlan S; Strle F
Wien Klin Wochenschr; 2002 Jul; 114(13-14):586-90. PubMed ID: 12422606
[TBL] [Abstract][Full Text] [Related]
2. Comparison of different Borrelia burgdorferi sensu lato strains for detection of immune response in patients with erythema migrans.
Merljak Skocir L; Ruzić-Sabljić E; Maraspin-Carman V; Lotric-Furlan S; Logar M; Strle F
Int J Med Microbiol; 2008 Jul; 298(5-6):493-504. PubMed ID: 17892971
[TBL] [Abstract][Full Text] [Related]
3. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.
Stanek G; Breier F; Menzinger G; Schaar B; Hafner M; Partsch H
Wien Klin Wochenschr; 1999 Dec; 111(22-23):951-6. PubMed ID: 10666807
[TBL] [Abstract][Full Text] [Related]
4. Has the presence or absence of Borrelia burgdorferi sensu lato as detected by skin culture any influence on the course of erythema migrans?
Logar M; Lotric-Furlan S; Maraspin V; Cimperman J; Jurca T; Ruzić-Sabljić E; Strle F
Wien Klin Wochenschr; 1999 Dec; 111(22-23):945-50. PubMed ID: 10666806
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of culture and polymerase chain reaction for the etiologic diagnosis of erythema migrans.
Zore A; Ruzić-Sabljić E; Maraspin V; Cimperman J; Lotric-Furlan S; Pikelj A; Jurca T; Logar M; Strle F
Wien Klin Wochenschr; 2002 Jul; 114(13-14):606-9. PubMed ID: 12422609
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Borrelia burgdorferi sensu lato strains isolated from human material in Slovenia.
Ruzić-Sabljić E; Maraspin V; Lotric-Furlan S; Jurca T; Logar M; Pikelj-Pecnik A; Strle F
Wien Klin Wochenschr; 2002 Jul; 114(13-14):544-50. PubMed ID: 12422599
[TBL] [Abstract][Full Text] [Related]
7. Development and laboratory evaluation of a new recombinant ELISA for the serodiagnosis of Lyme disease.
Hunfeld KP; Ernst M; Zachary P; Jaulhac B; Sonneborn HH; Brade V
Wien Klin Wochenschr; 2002 Jul; 114(13-14):580-5. PubMed ID: 12422605
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of two enzyme linked immunosorbent assay methods and three Western Blot methods for the diagnosis of culture-confirmed early Lyme borreliosis in Italy.
Marangoni A; Sparacino M; Mondardini V; Cavrini F; Storni E; Donati M; Cevenini R; Sambri V
New Microbiol; 2005 Jan; 28(1):37-43. PubMed ID: 15782625
[TBL] [Abstract][Full Text] [Related]
9. [Borrelia strains that cause erythema migrans in Alsace, France].
Antoni-Bach N; Jaulhac B; Hansmann Y; Limbach F; Lipsker D
Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):15-8. PubMed ID: 11937923
[TBL] [Abstract][Full Text] [Related]
10. Comparison of four different serological methods for detection of antibodies to Borrelia burgdorferi in erythema migrans.
Olsson I; von Stedingk LV; Hanson HS; von Stedingk M; Asbrink E; Hovmark A
Acta Derm Venereol; 1991; 71(2):127-33. PubMed ID: 1675520
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of test with antigen VlsE (C6) with tests with recombinant antigens in patients with Lyme borreliosis].
Zajkowska JM; Kondrusik M; Pancewicz SA; Grygorczuk S; Jamiołkowski J; Stalewska J
Pol Merkur Lekarski; 2007 Aug; 23(134):95-9. PubMed ID: 18044336
[TBL] [Abstract][Full Text] [Related]
12. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
[TBL] [Abstract][Full Text] [Related]
13. European Lyme borreliosis: 231 culture-confirmed cases involving patients with erythema migrans.
Strle F; Nelson JA; Ruzic-Sabljic E; Cimperman J; Maraspin V; Lotric-Furlan S; Cheng Y; Picken MM; Trenholme GM; Picken RN
Clin Infect Dis; 1996 Jul; 23(1):61-5. PubMed ID: 8816130
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the human antibody response to outer surface protein C (OspC) of Borrelia burgdorferi sensu stricto, B. garinii, and B. afzelii.
Mathiesen MJ; Hansen K; Axelsen N; Halkier-Sørensen L; Theisen M
Med Microbiol Immunol; 1996 Nov; 185(3):121-9. PubMed ID: 9007816
[TBL] [Abstract][Full Text] [Related]
15. [Serodiagnosis of Lyme borreliosis: antibody titer and specificity in the IFT and western blot].
Grellner W; Erbguth F; Brade V
Immun Infekt; 1989 Dec; 17(6):189-94. PubMed ID: 2693341
[TBL] [Abstract][Full Text] [Related]
16. The impact of immunosuppression on erythema migrans. A retrospective study of clinical presentation, response to treatment and production of Borrelia antibodies in 33 patients.
Fürst B; Glatz M; Kerl H; Müllegger RR
Clin Exp Dermatol; 2006 Jul; 31(4):509-14. PubMed ID: 16716151
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous manifestations of Lyme borreliosis.
Berger BW
Rheum Dis Clin North Am; 1989 Nov; 15(4):627-34. PubMed ID: 2685922
[TBL] [Abstract][Full Text] [Related]
18. [Antibodies against Borrelia afzelli in patients with an early stage of Lyme disease].
Flisiak I; Chodynicka B
Wiad Lek; 2001; 54(1-2):19-25. PubMed ID: 11344697
[TBL] [Abstract][Full Text] [Related]
19. Children with multiple erythema migrans: are there any pre-treatment symptoms and/or signs suggestive for central nervous system involvement?
Arnez M; Pleterski-Rigler D; Luznik-Bufon T; Ruzić-Sabljić E; Strle F
Wien Klin Wochenschr; 2002 Jul; 114(13-14):524-9. PubMed ID: 12422594
[TBL] [Abstract][Full Text] [Related]
20. Use of western blot and enzyme-linked immunosorbent assays to assist in the diagnosis of Lyme disease.
Rose CD; Fawcett PT; Singsen BH; Dubbs SB; Doughty RA
Pediatrics; 1991 Sep; 88(3):465-70. PubMed ID: 1881724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
